Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies

BACKGROUND: Studies have shown increased gastric cancer risk in users of proton pump inhibitors (PPI) and histamine-2 receptor antagonists, questioning the safety of gastric acid suppression. Therefore, we conducted a case–control study within the Scottish Primary Care Clinical Informatics Unit (PCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peipei, McMenamin, Úna C., Johnston, Brian T., Murchie, Peter, Iversen, Lisa, Lee, Amanda J., Vissers, Pauline A. J., Cardwell, Chris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374738/
https://www.ncbi.nlm.nih.gov/pubmed/32367073
http://dx.doi.org/10.1038/s41416-020-0860-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374738/
https://www.ncbi.nlm.nih.gov/pubmed/32367073
http://dx.doi.org/10.1038/s41416-020-0860-4

Ejemplares similares